A major French operator, the Doctegestio group, has launched a new platform called Avec which combines everything from dentistry and primary care to hospital and nursing homes. We talk to Bernard Bensaid, the entrepreneur behind Avec.
Rumours are swirling of a bid for Orpea, the scandal-hit pan-European care group. According to the rumours, another large French care home group is preparing a bid for Orpea. We hear this from a UK advisory source who named the buyer.
French elderly care giant Korian has been dragged into the controversy surrounding the French nursing home sector. A lawyer is launching a group lawsuit against the company based on the experiences of some of the residents at its nursing homes. HBI speaks to financial analysts to find out what the potential long term impact on the sector might be of this, and the ongoing Orpea crisis.
With all the recent well publicised criticisms of care homes in France, the spotlight is very much on quality in the sector. Who better to talk to then than Andrew Knight, CEO of Care UK, which according to UK healthcare watchdog the Care Quality Commission, has 16% outstanding sites against a market average of 4%, and 89% of its sites are rated good or outstanding.
Elections in the Netherlands last year saw Mark Rutte, the Liberal prime minister, return for a fourth term, and belatedly we now have a new cabinet. Could we see a new direction for healthcare following this new mandate?
Luxembourg-based REIT Threestones Capital has just acquired three nursing homes in Germany. HBI catches up with Threestones Capital co-founder, Giovanni Perin, and talks to Xavier Cheval, head of healthcare property at major European REIT Icade, to find out what impact the Orpea scandal is having on elderly care real estate as an asset class.
The French government has opened an investigation into nursing home giant Orpea and the company has terminated its CEO. This comes after a tumultuous week for the company in which allegations of widespread malpractice in its French nursing homes were published and its share price halved. Could Orpea be vulnerable to a bid?
The share prices of Europe’s two nursing home giants, Orpea and Korian, both plummeted on Monday, after extracts from a book about Orpea containing allegations of malpractice were published in French newspaper Le Monde. Orpea, whose shares have halved in value, strongly rejects the allegations.
Additional capacity is sorely needed in UK care homes, but many operators tell us they are only building facilities for privately paying residents. Local authority places do not pay enough to make it worthwhile, they say. HBI talks to three operators to find out more about this looming crisis.
Nursing homes were firmly in the spotlight for all the wrong reasons as the pandemic hit at the start of 2020. Mortality rates were high, morale was low, and huge reputational damage was done. Two years on, HBI speaks to three European operators to find out how the market is recovering.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.